Glukoza Viaflo Baxter

Glukoza Viaflo Baxter is an injectable solution containing the active ingredient glucose. It is supplied as a parenteral nutrition product in an intravenous injection form, marketed in the European Union. The preparation provides a readily available source of carbohydrate energy for patients requiring intravenous glucose supplementation, such as those with hypoglycemia or needing fluid replacement.

Glukoza Viaflo Baxter is indicated for several clinical situations where intravenous glucose is required.

- Treatment of hypoglycemia when oral glucose is not feasible. - Component of parenteral nutrition regimens for patients unable to receive enteral feeding. - Fluid replacement in patients with electrolyte or volume deficits. - Support during surgical procedures or critical care when rapid glucose provision is needed. - Adjunct therapy in metabolic disorders requiring controlled glucose administration.

Glukoza Viaflo Baxter may be associated with a range of adverse reactions, most of which are related to its intravenous administration.

Common: - Local irritation or pain at the injection site. - Hyperglycemia when administered in excess. - Electrolyte imbalances, particularly sodium or potassium shifts. - Mild nausea or vomiting. - Transient headache.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic or anaphylactic reactions. - Phlebitis or thrombophlebitis at the infusion site. - Volume overload causing pulmonary edema. - Metabolic acidosis in susceptible patients.

When using Glukoza Viaflo Baxter, clinicians should consider several safety measures to minimize risk.

- Assess blood glucose levels before and during infusion to avoid hyperglycemia. - Monitor fluid balance and cardiac status, especially in patients with heart failure. - Use aseptic technique to prevent infection at the infusion site. - Adjust dosage in patients with renal or hepatic impairment. - Avoid rapid infusion rates that may cause osmotic shifts. - Review pregnancy status; the safety profile in pregnancy is not well established.

Glukoza Viaflo Baxter can interact with other medications or clinical conditions, requiring careful management.

Avoid: - Concurrent administration of high-dose insulin without glucose monitoring. - Co-administration with other hypertonic glucose solutions, which may exacerbate hyperglycemia. - Use with drugs that cause fluid retention in patients at risk for overload.

Use with caution: - Beta‑blockers, which may mask signs of hypoglycemia. - Corticosteroids, which can increase blood glucose levels. - Diuretics, which may affect electrolyte balance. - Medications affecting renal function, such as NSAIDs.